The Skin Barrier: How the Stratum Corneum Really Keeps Things Out

The skin does something so quietly effective that most people never think about it: it keeps the outside world outside. This article explains how the stratum corneum, the thin outermost layer of skin, actually accomplishes that job at a structural and chemical level, what happens when it is disrupted, and what the current evidence does and does not support about two materials often discussed alongside skin hygiene — silver and chitosan. It does not claim that any topical product treats, cures, or prevents disease. The goal is understanding, not persuasion.

A Wall a Few Thousandths of a Millimeter Thick

The stratum corneum is the outermost of five layers of the epidermis, and in most places on the body it is astonishingly thin — roughly 10 to 20 micrometers, about the thickness of plastic food wrap, though it is considerably thicker on the palms and soles where mechanical demand is higher. Despite its slightness, it is the primary reason a person can shower, sweat, walk through rain, and touch doorknobs all day without dissolving, drying out, or absorbing whatever happens to be on the surface they touched.

It is made of corneocytes: flattened, dead keratinocytes that have lost their nuclei and organelles in a carefully regulated process called cornification. These cells are not inert debris. Their internal structure is packed with keratin filaments and surrounded by a tough, cross-linked protein envelope, and they are arranged in overlapping layers, typically 10 to 20 cell layers deep, that are gradually shed and replaced as the skin renews itself over roughly two to four weeks.

The Brick-and-Mortar Model: How the Barrier Actually Works

The most useful way to understand the stratum corneum's function comes from work by dermatologist Peter Elias and colleagues at the University of California, San Francisco, beginning in the 1980s. Elias described the layer as functioning like a brick wall: the corneocytes are the bricks, and a continuous matrix of lipids — mainly ceramides, cholesterol, and free fatty acids — forms the mortar packed between them in ordered, multilayered sheets called lamellar bilayers.

This lipid mortar is what makes the barrier selective rather than absolute. Water-soluble substances and ions generally struggle to cross it, while small, lipid-soluble molecules can pass more readily. This is precisely the principle exploited by approved transdermal drug patches, such as those delivering nicotine or fentanyl, which are formulated specifically to exploit that lipid pathway — a reminder that the barrier is permeable in defined, exploitable ways, not simply impenetrable.

Neighboring corneocytes are also physically anchored to one another by structures called corneodesmosomes, which are broken down in a controlled way by enzymes called kallikreins as cells rise toward the surface, allowing orderly shedding rather than the skin flaking off in visible sheets. When this enzymatic process runs too fast or too slow, visible scaling or excessive greasiness can result, which is part of why conditions like ichthyosis and certain forms of eczema show characteristic changes in skin texture.

The stratum corneum also maintains its own hydration through natural moisturizing factor — a mix of free amino acids, urea, and lactic acid released when a structural protein called filaggrin breaks down. Alongside this sits the skin's acid mantle: healthy skin surface pH generally runs between about 4.7 and 5.75, according to skin-surface pH mapping research published in the International Journal of Cosmetic Science (Lambers et al., 2006), which measured pH across many body sites in healthy adults. That mild acidity is not incidental; it supports the enzymes responsible for lipid processing and desquamation and is inhospitable to many organisms that prefer a more neutral environment.

When the Barrier Fails: What the Genetics Teach Us

The clearest evidence for how important this structure is comes not from cosmetics research but from human genetics. A landmark study led by Irvine and McLean at the University of Dundee, published in Nature Genetics in 2006, established that loss-of-function mutations in the filaggrin gene are strongly associated with ichthyosis vulgaris and are a major genetic risk factor for atopic dermatitis. This is strong, well-replicated human evidence, not a cell-culture finding: people who cannot produce functional filaggrin have a measurably compromised barrier and a much higher rate of eczema.

Barrier integrity is commonly measured in research and clinical settings using transepidermal water loss (TEWL), a standard, well-validated instrument reading that reflects how much water is escaping through the skin. Elevated TEWL is a reliable marker of barrier disruption and has been used in decades of published dermatology research to compare the effects of soaps, solvents, low humidity, aging, and disease states on barrier function. Everyday factors that reliably raise TEWL and disrupt the lipid mortar include harsh surfactants (strong detergents and some soaps), excessive hot-water washing, low ambient humidity, and normal aging, which is associated with reduced lipid production and a measurable rise in surface pH. None of these findings involve any topical hygiene product; they describe the basic physiology of the barrier itself.

Silver and Chitosan: What the Materials Science Actually Shows

Silver has a long history of use on skin and wounds, and its antimicrobial behavior in the laboratory is genuinely well established. Silver ions bind readily to sulfhydryl (thiol) groups found in bacterial proteins and enzymes, and in vitro studies — meaning bacteria grown in culture, not living human skin — repeatedly show that this disrupts membrane function and enzymatic activity in a range of microorganisms. This mechanism is real and well documented in laboratory settings; silver sulfadiazine, a prescription drug distinct from cosmetic or chelated-silver products, is an FDA-approved treatment used for burns precisely because of this chemistry. It is worth noting explicitly that chelated silver used in non-drug topical or hygiene products is a different regulatory category from an approved drug, and no such non-drug product is approved by the FDA to treat, cure, or prevent infection. The FDA issued a final rule in 1999 stating that over-the-counter colloidal silver products are not generally recognized as safe and effective for the therapeutic uses then being claimed for them — a useful reminder that laboratory antimicrobial activity does not automatically translate into an approved medical claim, and that ingested colloidal silver carries a documented risk of argyria, a permanent blue-gray skin discoloration.

Chitosan is a different kind of material: a biopolymer derived from chitin, most commonly sourced from crustacean shells (and, less commonly, fungal cell walls), then processed into a positively charged polysaccharide. Its cationic charge allows it to interact with negatively charged surfaces, including cell membranes and mucosal tissue, and it readily forms thin, adherent films. This film-forming and charge-based behavior is why chitosan appears in hemostatic wound dressings, such as those developed for military and trauma use and cleared by the FDA as medical devices rather than drugs; published trauma-literature studies have measured reduced bleeding time with chitosan-based dressings in animal and some human trials. That hemostatic device application is distinct from cosmetic or hygiene-product use of chitosan as a film-forming ingredient, and readers should not conflate the two.

Combining a metal ion with a chelating or carrier molecule — producing what is generally called chelated silver — is a chemistry approach intended to moderate how and when silver ions are released, rather than delivering them all at once. This is a reasonable materials-engineering rationale, but it is a description of chemistry, not a clinical claim, and the available published evidence for chelated-silver hygiene products on human skin, as opposed to silver in culture dishes, remains limited and largely preliminary.

Hygiene as Practice, Not Substitute

None of this laboratory chemistry replaces basic hygiene practice, which remains the best-supported intervention for reducing the transmission of everyday organisms. A Cochrane systematic review on physical interventions to reduce respiratory virus spread, and separate Cochrane reviews on hand hygiene, have found consistent, if modest, benefit from regular handwashing with soap and water in reducing transmission of common respiratory and gastrointestinal illness — a finding grounded in decades of public-health research going back to Ignaz Semmelweis's nineteenth-century observation that handwashing among physicians sharply reduced childbed fever in maternity wards. Separately, Cochrane review evidence on occupational skin care shows that barrier creams and emollients can help protect the hands of workers who wash frequently, by supporting the lipid mortar that harsh, repeated washing strips away.

This is worth taking seriously as a matter of stewardship. The skin was made to do this job remarkably well on its own; the wisest use of any topical product is to support that design — keeping the barrier supple and intact — rather than to imagine that a cream or wash can substitute for sound hygiene habits, adequate handwashing, and sensible care of one's own household. Informed patients, working with their own physician, are in the best position to judge what belongs in that routine and what does not.

Where a Product Like GermProof Fits — and Its Limits

GermProof is a topical product formulated with chelated silver and chitosan, intended for use as part of a personal hygiene routine on intact skin. It is not an approved drug, and it is not intended, described, or represented here as a treatment, cure, or prevention for any disease or infection. Its ingredients are drawn from materials with a long history of study — silver ion chemistry and a chitin-derived biopolymer — but that history is a starting point for understanding the chemistry involved, not a substitute for regulatory approval or for a clinician's guidance on any specific health concern. Anyone considering a new topical product, particularly on broken skin, in infants, during pregnancy, or with a known sensitivity to metals, should discuss it with their own doctor or pharmacist before use.

Key takeaway: The stratum corneum is a genuinely well-engineered, selectively permeable barrier built from cells and lipids working together, and while materials like silver and chitosan have real, documented chemistry worth understanding, sound hygiene practice and an intact barrier remain the foundation of skin protection.